Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 3/20 | 0.62 |
| ▸ | CYP2D6 | P10635 | 3/20 | 0.59 |
| ▸ | ADRB2 | P07550 | 1/20 | 0.59 |
| ▸ | ADRB1 | P08588 | 1/20 | 0.59 |
| ▸ | ADRB3 | P13945 | 1/20 | 0.59 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.54 |
| ▸ | MAPT | P10636 | 4/20 | 0.53 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.53 |
| ▸ | TSHR | P16473 | 2/20 | 0.51 |
| ▸ | HTT | P42858 | 1/20 | 0.51 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.51 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.51 |
| ▸ | RECQL | P46063 | 1/20 | 0.51 |
| ▸ | POLB | P06746 | 2/20 | 0.50 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.50 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.50 |
| ▸ | MEN1 | O00255 | 1/20 | 0.49 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.49 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29620619 | 0.93 | LMNA (0.55) | LMNACYP2D6ADRB2ADRB1ADRB3 | |
| SCHEMBL25688257 | 0.91 | LMNA (0.53) | LMNACYP2D6ADRB2ADRB1ADRB3 | |
| SCHEMBL267463 | 0.89 | LMNA (0.68) | LMNACYP2D6ADRB2ADRB1ADRB3 | |
| SCHEMBL28727716 | 0.89 | KDM1A (0.58) | LMNACYP2D6ADRB2ADRB1ADRB3 | |
| SCHEMBL12222360 | 0.88 | LMNA (0.53) | LMNACYP2D6ADRB2ADRB1ADRB3 | |
| SCHEMBL12450281 | 0.88 | LMNA (0.53) | LMNACYP2D6ADRB2ADRB1ADRB3 | |
| SCHEMBL11888312 | 0.86 | MAPK1 (0.67) | LMNAADRB2ADRB1L3MBTL1MAPT | |
| SCHEMBL14904490 | 0.85 | LMNA (0.50) | LMNACYP2D6ADRB2ADRB1ADRB3 | |
| SCHEMBL14901479 | 0.84 | POLB (0.55) | LMNACYP2D6ADRB2ADRB1MAPT | |
| SCHEMBL14901482 | 0.84 | POLB (0.55) | LMNACYP2D6ADRB2ADRB1MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 33 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11535700-B2 | Epoxy polymer, epoxy resin, epoxy resin composition, resin sheet, b-stage sheet, cured product, c-stage sheet, metal foil with resin, metal substrate and method for manufacturing | SHOWA DENKO MATERIALS CO., LTD. (JP) | 2022-12-27 | — | — | US | disclosed |
| CN-109641823-B | Monomers, polymers, preparation method and use thereof | 东莞东阳光医疗智能器件研发有限公司 | 2022-05-06 | — | — | CN | disclosed |
| US-10968308-B2 | Preparation method of epoxy compound having alkoxysilyl group, epoxy compound having alkoxysilyl group, composition comprising the same, and use thereof | KOREA INSTITUTE OF INDUSTRIAL TECHNOLOGY (KR) | 2021-04-06 | — | — | US | disclosed |
| US-20190135970-A1 | PREPARATION METHOD OF EPOXY COMPOUND HAVING ALKOXYSILYL GROUP, EPOXY COMPOUND HAVING ALKOXYSILYL GROUP, COMPOSITION COMPRISING THE SAME, AND USE THEREOF | KOREA INSTITUTE OF INDUSTRIAL TECHNOLOGY (KR) | 2019-05-09 | — | — | US | disclosed |
| US-9857685-B2 | Photosensitive resin composition, resist laminate, cured product of photosensitive resin composition, and cured product of resist laminate (11) | NIPPON KAYAKU KABUSHIKI KAISHA (JP) | 2018-01-02 | — | — | US | disclosed |
| US-20170102614-A1 | Photosensitive Resin Composition, Resist Laminate, Cured Product Of Photosensitive Resin Composition, And Cured Product Of Resist Laminate (11) | NIPPON KAYAKU KABUSHIKI KAISHA (JP) | 2017-04-13 | — | — | US | disclosed |
| US-9541675-B2 | Photosensitive resin composition, light blocking layer using the same, and color filter | SAMSUNG SDI CO., LTD. (KR) | 2017-01-10 | — | — | US | disclosed |
| US-20150241600-A1 | Photosensitive Resin Composition, Light Blocking Layer Using the Same, and Color Filter | SAMSUNG SDI CO., LTD. (KR) | 2015-08-27 | — | — | US | disclosed |
| US-8648146-B2 | Activated solid support and method | GE HEALTHCARE BIO-SCIENCES AB (SE) | 2014-02-11 | — | — | US | disclosed |
| US-20120245301-A1 | ACTIVATED SOLID SUPPORT AND METHOD | GE HEALTHCARE BIO-SCIENCES AB (SE) | 2012-09-27 | — | — | US | disclosed |
| US-7473711-B2 | Androgen modulators | PFIZER INC. (US) | 2009-01-06 | — | — | US | disclosed |
| US-7309560-B2 | Composition for forming anti-reflective coating | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2007-12-18 | — | — | US | disclosed |
| US-20070197642-A1 | Androgen modulators | WARNER-LAMBERT COMPANY LLC | 2007-08-23 | — | — | US | disclosed |
| US-20070197642-A1 | Androgen modulators | WARNER-LAMBERT COMPANY LLC | 2007-08-23 | — | — | US | disclosed |
| US-20070190459-A1 | Resist underlayer coating forming composition for mask blank, mask blank and mask | HOYA CORPORATION (JP) | 2007-08-16 | — | — | US | disclosed |
| US-20070190459-A1 | Resist underlayer coating forming composition for mask blank, mask blank and mask | HOYA CORPORATION (JP) | 2007-08-16 | — | — | US | disclosed |
| EP-1740533-A1 | ANDROGEN MODULATORS | Warner-Lambert Company LLC (US) | 2007-01-10 | — | — | EP | disclosed |
| WO-2005102990-A1 | ANDROGEN MODULATORS | WARNER-LAMBERT COMPANY LLC (US) | 2005-11-03 | — | — | WO | disclosed |
| EP-0746310-A1 | CONTROLLED RELEASE COMPOSITION | BUKH MEDITEC A/S (DK) | 1996-12-11 | — | — | EP | disclosed |
| WO-1995022962-A1 | CONTROLLED RELEASE COMPOSITION | BM RESEARCH A/S (DK) | 1995-08-31 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120245301-A1 | ACTIVATED SOLID SUPPORT AND METHOD | OSTC, HLCS, SPR | LMNA 2495/4885CYP2D6 130/4885ADRB2 4175/4885 |
| US-20070197642-A1 | Androgen modulators | CYP17A1, NR5A1, SHBG | LMNA 4577/4885CYP2D6 237/4885ADRB2 181/4885 |
| US-10968308-B2 | Preparation method of epoxy compound having alkoxysilyl group, epoxy compound having alkoxysilyl group, composition comprising the same, and use thereof | EGLN1, ALKBH3, EPHX2 | LMNA 723/4885CYP2D6 772/4885ADRB2 3533/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.